DebbieChen

Associate

Irvine + 1.949.553.7545

Contact

Partager

Debbie Chen advises public and private companies on corporate law matters. She has represented clients in domestic and cross-border mergers, acquisitions, and SEC compliance. In addition, she has experience advising companies on corporate governance matters and legal opinions.

Debbie has represented clients in a broad range of industries, including medical devices, agriculture, and technology. She also maintains an active pro bono practice, advising nonprofits on corporate governance matters and representing survivors of human trafficking in obtaining various forms of relief.

Expérience

  • Reneo Pharmaceuticals announces reverse merger with OnKureJones Day is representing Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) in an all-stock reverse merger between Reneo and OnKure, Inc., a privately-held, clinical-stage biopharmaceutical company valued at $170 million that is focused on the development of novel precision medicines in oncology.
  • VSE acquires assets and license from HoneywellJones Day advised VSE Corporation in the $105 million asset purchase and perpetual license agreement to manufacture and support certain of Honeywell International’s fuel control systems on four key engine platforms.
  • Sumitomo acquires assets and rights related to lefamulin from NabrivaJones Day advised Sumitomo Pharma Co., Ltd. in the acquisition of assets from Nabriva Therapeutics plc and various wholly-owned subsidiaries. This acquisition includes assets from the U.S., Ireland, and Austria in support of the development, manufacture, marketing and commercialization of lefamulin in the People’s Republic of China, Hong Kong, Macau and Taiwan.
  • Astellas acquires Iveric bioJones Day advised Astellas Pharma Inc. in the $5.9 billion cash acquisition of Iveric bio, Inc., a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs.
  • Cibus combines with CalyxtJones Day advised Cibus Global, LLC (“Cibus”), a San Diego based leader in precision gene editing in agriculture, in connection with an all-stock merger with Calyxt, Inc. (NASDAQ: CLXT), under which Cibus and Calyxt created an industry-leading company that combines two pioneers in agriculture-based gene editing and establishes one of the world’s most sophisticated facilities for trait development and plant breeding.
  • Meridian Bioscience agrees to be acquired by SD Biosensor and SJL Partners in $1.53 billion all-cash transactionJones Day advised Meridian Bioscience, Inc. in its $1.53 billion all-cash acquisition by SD Biosensor and SJL Partners.
  • Organon makes strategic investment in Claria MedicalJones Day advised Organon in the strategic investment in Claria Medical, Inc. a privately-held company developing an investigational medical device being studied for use during minimally invasive laparoscopic hysterectomy.
  • Engage PEO acquires Fusion Employer ServicesJones Day advised Engage PEO in the acquisition of Fusion Employer Services, a Lawrenceville, New Jersey-based professional employer organization which has deep roots in the New Jersey market and a reputation for high-quality specialty services, including payroll and tax, human resources management, a full range of benefits, 401(k), and workers' compensation.
  • Westpac invests in KasistoJones Day advised Westpac Banking Corporation in relation to its investment in a New York-based conversational artificial intelligence industry leader, Kasisto, Inc.
  • Engage PEO acquires CEOHR, Inc.Jones Day advised Engage PEO in the acquisition of CEOHR, Inc., a Sarasota, Florida-based professional employer organization.
  • NerdWallet acquires On The Barrelhead for $120 millionJones Day advised NerdWallet, Inc. (Nasdaq: NRDS), a platform that provides financial guidance to consumers and small- and mid-sized businesses, in its acquisition of On the Barrelhead, Inc. for total consideration of $120 million, consisting of approximately $70 million in cash and $50 million in NerdWallet Class A common stock.
  • National bank provides $95 million syndicated loan secured by multifamily properties located in CaliforniaJones Day represented a national bank, as administrative agent and lead lender, in connection with a $95 million syndicated loan secured by multifamily properties located in California.
  • Hookit sells company to Kore SoftwareJones Day advised Hookit in the sale of 100% of Hookit’s stock to KORE Software, a portfolio company of Serent Capital.
  • Riverside portfolio company acquires AptoJones Day represented The Riverside Company in connection with the acquisition and financing by portfolio company Buildout, Inc. of Apto, a premier provider of CRM and deal management software for commercial real estate (CRE) brokers.
  • Sempra Energy sells PXiSE Energy SolutionsJones Day advised Sempra Energy in the sale of membership interests in PXiSE Energy Solutions to Yokogawa Electric Corporation.
  • Hilti Group acquires Fieldwire for approximately $300 millionJones Day advised the Hilti Group in its acquisition of Fieldwire, a San Francisco, California, based construction technology company specialized in construction project management software, for approximately $300 million.
  • Sotera Health acquires Regulatory Compliance AssociatesJones Day advised Sotera Health in the acquisition of Wisconsin-based Regulatory Compliance Associates, Inc.
  • Misonix merges with BioventusJones Day represented Misonix, Inc. (Nasdaq: MSON) in its acquisition by Bioventus Inc. (Nasdaq: BVS).
  • NEP acquires Prysm Collective, Lux Machina And Halon EntertainmentJones Day advised NEP Group in the acquisition of Prysm Collective, Lux Machina and Halon Entertainment.
  • Uniphore raises capital in Series D roundJones Day represented Uniphore Technologies Inc., a conversational AI platform providing automation, analytics, assistant and security services, in its issuance of Series D Preferred Stock, which was led by Sorenson Capital Partners.
    •

    June 2021 Commentary

    SEC Awards $28 Million+ to Whistleblower for Tip Relating to 2018 FCPA Settlements

    Avant d’envoyer cet e-mail, veuillez prendre note de ce qui suit :

    Les informations contenues sur le site www.jonesday.com sont destinées à un usage général et ne constituent pas des conseils juridiques. L’envoi et la réception de cet e-mail n’ont pas pour effet de créer une relation avocat-client. Aucun envoi de votre part à un membre du Cabinet ne sera traité comme confidentiel ou protégé à moins que nous n’ayons donné notre accord pour vous représenter. En envoyant cet e-mail, vous confirmez avoir lu et compris la présente notification.